---
ver: rpa2
title: 'HoneyBee: A Scalable Modular Framework for Creating Multimodal Oncology Datasets
  with Foundational Embedding Models'
arxiv_id: '2405.07460'
source_url: https://arxiv.org/abs/2405.07460
tags:
- data
- datasets
- embeddings
- medical
- honeybee
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: HONeYBEE is a scalable framework for creating multimodal oncology
  datasets with foundational model embeddings. It integrates clinical records, imaging
  data, and molecular profiles, using transformer-based models to generate unified
  patient embeddings.
---

# HoneyBee: A Scalable Modular Framework for Creating Multimodal Oncology Datasets with Foundational Embedding Models
## Quick Facts
- **arXiv ID**: 2405.07460
- **Source URL**: https://arxiv.org/abs/2405.07460
- **Reference count**: 27
- **Primary result**: HONeYBEE achieved 98.5% classification accuracy and 96.4% precision@10 in patient retrieval using clinical embeddings across 11,400+ TCGA patients and 33 cancer types

## Executive Summary
HONeYBEE is a scalable framework designed to create multimodal oncology datasets using foundational embedding models. The framework integrates clinical records, imaging data, and molecular profiles through transformer-based models to generate unified patient embeddings. Evaluated on TCGA data across 33 cancer types, the system demonstrated strong performance in cancer-type classification, patient retrieval, and survival prediction tasks. The framework's modular design enables integration of diverse data modalities while maintaining task-specific performance through fine-tuning capabilities.

## Method Summary
HONeYBEE employs a modular architecture that processes multimodal oncology data through specialized embedding models. The framework ingests clinical records, imaging data, and molecular profiles, converting each modality into vector embeddings using transformer-based models. These embeddings are then fused through multimodal integration techniques to create comprehensive patient representations. The system supports both general-purpose embeddings and task-specific fine-tuning, enabling adaptation to heterogeneous data types such as pathology reports and radiology images. The architecture emphasizes scalability through parallel processing pipelines and standardized data transformation protocols.

## Key Results
- Clinical embeddings achieved 98.5% accuracy in cancer-type classification across 33 cancer types
- Patient retrieval precision@10 reached 96.4% using clinical embeddings
- Multimodal fusion improved survival prediction performance for select cancer types compared to single-modality approaches

## Why This Works (Mechanism)
HONeYBEE leverages transformer-based foundational models' ability to capture complex patterns across heterogeneous data modalities. The framework's strength lies in its modular design that allows each data type to be processed by specialized models optimized for that modality's characteristics. Clinical text benefits from language model pretraining, while imaging data utilizes convolutional and vision transformer architectures. The multimodal fusion component integrates these distinct representations into unified patient embeddings that capture complementary information across clinical, imaging, and molecular domains. Task-specific fine-tuning enables the system to adapt to domain-specific nuances in oncology data, particularly important for heterogeneous data sources like pathology reports with varying formats and terminologies.

## Foundational Learning
- **Transformer-based embeddings**: Why needed - capture complex patterns in multimodal data; Quick check - verify model architecture matches task requirements
- **Multimodal fusion techniques**: Why needed - integrate complementary information across data types; Quick check - evaluate fusion performance against single-modality baselines
- **Fine-tuning protocols**: Why needed - adapt general-purpose models to domain-specific oncology data; Quick check - measure performance improvement after fine-tuning
- **Scalability principles**: Why needed - handle large oncology datasets with multiple data types; Quick check - test framework performance with increasing dataset sizes
- **Domain adaptation**: Why needed - bridge gap between model pretraining data and specialized oncology data; Quick check - compare performance across different institutional datasets
- **Embedding standardization**: Why needed - ensure consistent vector representations across modalities; Quick check - verify embedding dimensionality and normalization

## Architecture Onboarding
**Component map**: Data Ingestion -> Modality-specific Processing -> Embedding Generation -> Multimodal Fusion -> Task-specific Fine-tuning -> Output

**Critical path**: The most performance-critical components are the modality-specific embedding models and the multimodal fusion layer. Clinical text processing and molecular profile embeddings typically have the highest impact on downstream task performance.

**Design tradeoffs**: The framework balances between using large general-purpose models versus smaller domain-specific models. General-purpose models offer broader knowledge but may require more fine-tuning data, while domain-specific models provide better initial performance but may lack generalizability.

**Failure signatures**: Poor performance often manifests as modality-specific failures - clinical embeddings may underperform with non-standard note formats, while imaging embeddings struggle with low-quality or atypical scan types. Multimodal fusion failures typically appear as redundant or conflicting information integration.

**First experiments**:
1. Single-modality classification task to establish baseline performance per data type
2. Ablation study removing individual modalities to quantify contribution to multimodal performance
3. Cross-validation across different cancer types to assess generalization capability

## Open Questions the Paper Calls Out
None

## Limitations
- Evaluation limited to TCGA dataset, raising questions about generalizability to other oncology cohorts
- Clinical note embeddings showed lower performance compared to other modalities, suggesting domain adaptation challenges
- Multimodal survival prediction improvements were inconsistent across cancer types, indicating potential cancer-type dependencies

## Confidence
- Clinical embedding performance claims (High confidence): Well-supported by reported metrics and validation approach
- Multimodal survival prediction improvements (Medium confidence): Significant but inconsistent across cancer types with relatively small effect sizes
- Framework generalizability claims (Low confidence): Based on internal benchmarking rather than external dataset testing

## Next Checks
1. External validation on non-TCGA oncology datasets to assess model performance degradation and domain adaptation requirements across different healthcare systems
2. Ablation studies testing individual embedding model contributions to determine whether performance is driven by specific components or genuine multimodal integration benefits
3. Temporal validation using time-split data to evaluate whether embeddings maintain predictive power when applied to more recent patient cohorts, addressing potential data drift